Thursday, March 26, 2020

Doxycycline – USA

›
On Mar 25, 2020, Federal Circuit affirmed-in part infringement of Chang patents & revesed-in part district court’s decision of Ashley...
Wednesday, March 18, 2020

Efinaconazole – USA

›
On Mar. 13, 2020, Federal Circuit reversed PTAB’s claim construction & thus vacated final written decision and remanded matter back t...
Tuesday, March 17, 2020

Linagliptin – USA

›
On Mar. 16, 2020, Federal Circuit reversed in-part & affirmed in-part district court’s decision in a case involving DPP-IV inhibito...
Friday, March 6, 2020

Infliximab – USA

›
On Mar. 05, 2020, Federal Circuit (Rule 36 judgment) upheld a Massachusetts court’s decision that Celltrion’s biosimilar Inflectra (infli...
Wednesday, February 26, 2020

Diclofenac – USA

›
On Feb 25, 2020, Full Federal Circuit denied Horizon’s petition for en banc rehearing over indefiniteness ruling. Previously on Oct 1...
Tuesday, February 25, 2020

Neridronic acid - USA

›
Decision on PGR: Feb 25, 2020 AIA Review Filing Date Institution Date Petitioner US Patent ...
1 comment:
Friday, February 21, 2020

Fremanezumab / Galcanezumab - USA

›
IPR decision: Feb 18, 2020 AIA Review # Filing Date Institution Date Petitioner Patent ...
Wednesday, February 19, 2020

Vortioxetine - USA

›
Claim Construction (District of Delaware): Feb 18, 2020 Pending before the Court is the parties' second set of claim construction ...
Tuesday, February 11, 2020

Mifepristone - USA

›
IPR decision: Feb 10, 2020 AIA Review # Filing Date Institution Date Petitioner Patent ...
2 comments:
Friday, February 7, 2020

Alogliptin & combinations – USA

›
On Feb 04, 2020, Judge Stanley R. Chesler of New Jersey found claims of alogliptin compound patent valid & infringed. Takeda (Pla...